Enliven Therapeutics, Inc. (ELVN)
NASDAQ: ELVN · Real-Time Price · USD
21.39
-0.36 (-1.66%)
At close: Oct 17, 2025, 4:00 PM EDT
21.41
+0.02 (0.09%)
After-hours: Oct 17, 2025, 4:32 PM EDT
Enliven Therapeutics Market Cap
Enliven Therapeutics has a market cap or net worth of $1.27 billion as of October 17, 2025. Its market cap has increased by 6.12% in one year.
Market Cap
1.27B
Enterprise Value
778.31M
1-Year Change
6.12%
Ranking
Category
Stock Price
$21.39
Market Cap Chart
Since February 24, 2023, Enliven Therapeutics's market cap has increased from $974.02M to $1.27B, an increase of 30.21%. That is a compound annual growth rate of 10.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 17, 2025 | 1.27B | 15.36% |
| Dec 31, 2024 | 1.10B | 92.74% |
| Dec 29, 2023 | 570.37M | -41.44% |
| Feb 24, 2023 | 974.02M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 720.73B |
| Johnson & Johnson | 465.34B |
| AbbVie | 405.55B |
| UnitedHealth Group | 322.96B |
| AstraZeneca | 260.83B |
| Novartis AG | 254.64B |
| Novo Nordisk | 237.72B |
| Abbott Laboratories | 223.72B |